| actin cytoskeleton organization | GO:0030036 | 220 | 0.197 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.121 | |
| developmental maturation | GO:0021700 | 193 | 0.111 | |
| regionalization | GO:0003002 | 337 | 0.105 | |
| regulation of striated muscle cell differentiation | GO:0051153 | 81 | 0.103 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.094 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.091 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.081 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.081 | |
| cell adhesion | GO:0007155 | 329 | 0.080 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.077 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.077 | |
| vagus nerve development | GO:0021564 | 3 | 0.075 | |
| dendrite development | GO:0016358 | 115 | 0.074 | |
| gonad development | GO:0008406 | 141 | 0.074 | |
| neuron projection guidance | GO:0097485 | 141 | 0.071 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.067 | |
| regulation of canonical wnt signaling pathway | GO:0060828 | 82 | 0.065 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.064 | |
| amine metabolic process | GO:0009308 | 45 | 0.064 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.063 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.061 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.060 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.058 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.058 | |
| mesodermal cell migration | GO:0008078 | 4 | 0.057 | |
| muscle tissue development | GO:0060537 | 308 | 0.056 | |
| compound eye development | GO:0048749 | 1 | 0.056 | |
| cell proliferation in forebrain | GO:0021846 | 30 | 0.055 | |
| organ growth | GO:0035265 | 117 | 0.055 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.054 | |
| proteoglycan biosynthetic process | GO:0030166 | 20 | 0.054 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.053 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.052 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.052 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.052 | |
| axon guidance | GO:0007411 | 141 | 0.051 | |
| asymmetric neuroblast division | GO:0055059 | 1 | 0.051 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.050 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.050 | |
| rhythmic process | GO:0048511 | 174 | 0.050 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.049 | |
| regulation of ovulation | GO:0060278 | 3 | 0.049 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.049 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.049 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.049 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.047 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.047 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.046 | |
| mapk cascade | GO:0000165 | 281 | 0.046 | |
| respiratory system development | GO:0060541 | 190 | 0.046 | |
| nerve development | GO:0021675 | 67 | 0.045 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.045 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.044 | |
| regulation of asymmetric cell division | GO:0009786 | 4 | 0.044 | |
| gliogenesis | GO:0042063 | 141 | 0.044 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.044 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.044 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.043 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.043 | |
| positive regulation of secondary heart field cardioblast proliferation | GO:0072513 | 4 | 0.043 | |
| positive regulation of neuron projection development | GO:0010976 | 79 | 0.043 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.042 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.042 | |
| gtp catabolic process | GO:0006184 | 143 | 0.042 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.042 | |
| urogenital system development | GO:0001655 | 261 | 0.041 | |
| alpha beta t cell differentiation | GO:0046632 | 69 | 0.041 | |
| limb morphogenesis | GO:0035108 | 149 | 0.041 | |
| chemotaxis | GO:0006935 | 247 | 0.041 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.041 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.041 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.040 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.039 | |
| non canonical wnt signaling pathway via jnk cascade | GO:0038031 | 3 | 0.039 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.039 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.038 | |
| organelle fission | GO:0048285 | 170 | 0.037 | |
| cell fate commitment | GO:0045165 | 210 | 0.037 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.037 | |
| monosaccharide metabolic process | GO:0005996 | 106 | 0.037 | |
| axonogenesis | GO:0007409 | 274 | 0.037 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.036 | |
| forebrain development | GO:0030900 | 302 | 0.036 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.036 | |
| male gamete generation | GO:0048232 | 285 | 0.036 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.035 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.035 | |
| cranial nerve development | GO:0021545 | 41 | 0.035 | |
| dorsal ventral axon guidance | GO:0033563 | 3 | 0.035 | |
| neural tube closure | GO:0001843 | 90 | 0.035 | |
| digestive system development | GO:0055123 | 200 | 0.035 | |
| negative regulation of canonical wnt signaling pathway | GO:0090090 | 51 | 0.035 | |
| b cell activation | GO:0042113 | 161 | 0.035 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.034 | |
| carbohydrate biosynthetic process | GO:0016051 | 74 | 0.034 | |
| telencephalon development | GO:0021537 | 186 | 0.034 | |
| cell maturation | GO:0048469 | 127 | 0.033 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.033 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.033 | |
| spermatogenesis | GO:0007283 | 284 | 0.033 | |
| cellular response to amino acid stimulus | GO:0071230 | 29 | 0.033 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.032 | |
| skeletal muscle cell differentiation | GO:0035914 | 66 | 0.032 | |
| pharynx development | GO:0060465 | 1 | 0.032 | |
| glossopharyngeal nerve morphogenesis | GO:0021615 | 4 | 0.032 | |
| neuroblast differentiation | GO:0014016 | 2 | 0.032 | |
| oxidation reduction process | GO:0055114 | 342 | 0.032 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.031 | |
| adaptive immune response | GO:0002250 | 155 | 0.031 | |
| positive regulation of growth | GO:0045927 | 104 | 0.031 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.031 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.031 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.031 | |
| visceral motor neuron differentiation | GO:0021524 | 3 | 0.031 | |
| gastrulation | GO:0007369 | 116 | 0.031 | |
| protein ubiquitination | GO:0016567 | 171 | 0.031 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.031 | |
| glucose metabolic process | GO:0006006 | 92 | 0.030 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.030 | |
| myotube differentiation | GO:0014902 | 105 | 0.030 | |
| hexose metabolic process | GO:0019318 | 98 | 0.030 | |
| asymmetric stem cell division | GO:0098722 | 3 | 0.030 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.030 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.030 | |
| bone development | GO:0060348 | 120 | 0.030 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.030 | |
| gonad morphogenesis | GO:0035262 | 1 | 0.029 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.029 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.029 | |
| regulation of protein localization | GO:0032880 | 231 | 0.029 | |
| rhombomere formation | GO:0021594 | 1 | 0.029 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.029 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.029 | |
| response to acid chemical | GO:0001101 | 111 | 0.029 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.028 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.028 | |
| lung development | GO:0030324 | 164 | 0.028 | |
| primary neural tube formation | GO:0014020 | 95 | 0.028 | |
| regulation of interleukin 8 production | GO:0032677 | 3 | 0.028 | |
| negative regulation of wnt signaling pathway | GO:0030178 | 73 | 0.028 | |
| forebrain radial glial cell differentiation | GO:0021861 | 4 | 0.028 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.028 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.028 | |
| immunoglobulin production | GO:0002377 | 73 | 0.028 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.027 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.027 | |
| mammary gland duct morphogenesis | GO:0060603 | 38 | 0.027 | |
| blastocyst development | GO:0001824 | 80 | 0.027 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.026 | |
| actin filament organization | GO:0007015 | 113 | 0.026 | |
| ear morphogenesis | GO:0042471 | 118 | 0.026 | |
| negative regulation of neuron projection development | GO:0010977 | 50 | 0.026 | |
| stem cell differentiation | GO:0048863 | 268 | 0.026 | |
| membrane organization | GO:0061024 | 245 | 0.026 | |
| connective tissue development | GO:0061448 | 179 | 0.026 | |
| defecation | GO:0030421 | 1 | 0.026 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.025 | |
| negative regulation of transferase activity | GO:0051348 | 85 | 0.025 | |
| vagus nerve morphogenesis | GO:0021644 | 2 | 0.025 | |
| positive regulation of epithelial cell proliferation involved in lung morphogenesis | GO:0060501 | 3 | 0.025 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.025 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.025 | |
| exocrine system development | GO:0035272 | 45 | 0.025 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.025 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.025 | |
| intracellular protein transport | GO:0006886 | 204 | 0.025 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.025 | |
| lateral inhibition | GO:0046331 | 1 | 0.025 | |
| sulfur compound biosynthetic process | GO:0044272 | 37 | 0.025 | |
| digestive tract development | GO:0048565 | 190 | 0.025 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.025 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.024 | |
| endodermal cell fate specification | GO:0001714 | 4 | 0.024 | |
| glial cell differentiation | GO:0010001 | 131 | 0.024 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.024 | |
| gene silencing by rna | GO:0031047 | 19 | 0.024 | |
| circadian rhythm | GO:0007623 | 114 | 0.024 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.024 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.024 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.024 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.024 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.024 | |
| regulation of myotube differentiation | GO:0010830 | 62 | 0.024 | |
| neural tube development | GO:0021915 | 160 | 0.024 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.023 | |
| neuron migration | GO:0001764 | 122 | 0.023 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.023 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.023 | |
| sensory system development | GO:0048880 | 3 | 0.023 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.023 | |
| intracellular receptor signaling pathway | GO:0030522 | 74 | 0.023 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.023 | |
| cardiac muscle cell differentiation | GO:0055007 | 69 | 0.023 | |
| oviduct development | GO:0060066 | 3 | 0.023 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.023 | |
| cytokine production | GO:0001816 | 319 | 0.023 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.023 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.023 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.023 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.023 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.023 | |
| nuclear division | GO:0000280 | 158 | 0.023 | |
| placenta development | GO:0001890 | 140 | 0.022 | |
| regulation of carbohydrate biosynthetic process | GO:0043255 | 40 | 0.022 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.022 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.022 | |
| neuron death | GO:0070997 | 154 | 0.022 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.022 | |
| nuclear transport | GO:0051169 | 139 | 0.022 | |
| his purkinje system cell differentiation | GO:0060932 | 2 | 0.022 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.022 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.022 | |
| protein catabolic process | GO:0030163 | 221 | 0.022 | |
| regulation of tongue muscle cell differentiation | GO:2001035 | 2 | 0.022 | |
| spermatid differentiation | GO:0048515 | 115 | 0.021 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.021 | |
| transmembrane transport | GO:0055085 | 412 | 0.021 | |
| dna metabolic process | GO:0006259 | 303 | 0.021 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.021 | |
| regulation of mesenchymal cell proliferation involved in ureter development | GO:0072199 | 3 | 0.021 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.021 | |
| chondrocyte differentiation | GO:0002062 | 72 | 0.021 | |
| mesoderm morphogenesis | GO:0048332 | 64 | 0.021 | |
| rna interference | GO:0016246 | 2 | 0.021 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.021 | |
| tube formation | GO:0035148 | 140 | 0.021 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.021 | |
| sensory perception of mechanical stimulus | GO:0050954 | 107 | 0.021 | |
| specification of organ identity | GO:0010092 | 30 | 0.021 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.021 | |
| regulation of cardiac chamber morphogenesis | GO:1901219 | 2 | 0.020 | |
| histone modification | GO:0016570 | 159 | 0.020 | |
| formation of primary germ layer | GO:0001704 | 77 | 0.020 | |
| positive regulation of cell projection organization | GO:0031346 | 95 | 0.020 | |
| chromatin modification | GO:0016568 | 187 | 0.020 | |
| protein targeting | GO:0006605 | 143 | 0.020 | |
| zygotic determination of anterior posterior axis embryo | GO:0007354 | 3 | 0.020 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.020 | |
| cell growth | GO:0016049 | 130 | 0.020 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.020 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.020 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.020 | |
| heart growth | GO:0060419 | 45 | 0.020 | |
| positive regulation of striated muscle cell differentiation | GO:0051155 | 35 | 0.019 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.019 | |
| response to growth factor | GO:0070848 | 198 | 0.019 | |
| fat cell differentiation | GO:0045444 | 160 | 0.019 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.019 | |
| protein autophosphorylation | GO:0046777 | 61 | 0.019 | |
| immune effector process | GO:0002252 | 321 | 0.019 | |
| endochondral bone morphogenesis | GO:0060350 | 50 | 0.019 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.019 | |
| negative regulation of mesenchymal cell proliferation | GO:0072201 | 3 | 0.019 | |
| regulation of binding | GO:0051098 | 111 | 0.019 | |
| organelle localization | GO:0051640 | 179 | 0.019 | |
| lymphocyte homeostasis | GO:0002260 | 64 | 0.019 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.019 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.019 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.019 | |
| cartilage development | GO:0051216 | 140 | 0.019 | |
| oocyte maturation | GO:0001556 | 18 | 0.019 | |
| renal system development | GO:0072001 | 225 | 0.019 | |
| neuron maturation | GO:0042551 | 29 | 0.018 | |
| segmentation | GO:0035282 | 93 | 0.018 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.018 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.018 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.018 | |
| stem cell proliferation | GO:0072089 | 117 | 0.018 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.018 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.018 | |
| hindbrain development | GO:0030902 | 128 | 0.018 | |
| regulation of lymphocyte differentiation | GO:0045619 | 107 | 0.018 | |
| chromatin organization | GO:0006325 | 206 | 0.018 | |
| negative regulation of ovulation | GO:0060280 | 1 | 0.018 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.018 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.018 | |
| negative regulation of myeloid cell differentiation | GO:0045638 | 38 | 0.018 | |
| somitogenesis | GO:0001756 | 69 | 0.018 | |
| regulation of protein complex assembly | GO:0043254 | 83 | 0.018 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.018 | |
| negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090101 | 61 | 0.018 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.018 | |
| aortic valve morphogenesis | GO:0003180 | 4 | 0.018 | |
| heart formation | GO:0060914 | 16 | 0.018 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.018 | |
| non canonical wnt signaling pathway involved in heart development | GO:0061341 | 3 | 0.018 | |
| signal transduction by p53 class mediator | GO:0072331 | 51 | 0.018 | |
| positive regulation of t cell differentiation in thymus | GO:0033089 | 13 | 0.018 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.017 | |
| regulation of glucose metabolic process | GO:0010906 | 60 | 0.017 | |
| cell migration involved in endocardial cushion formation | GO:0003273 | 3 | 0.017 | |
| i kappab kinase nf kappab signaling | GO:0007249 | 85 | 0.017 | |
| negative regulation of sequence specific dna binding transcription factor activity | GO:0043433 | 40 | 0.017 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.017 | |
| regulation of rho protein signal transduction | GO:0035023 | 71 | 0.017 | |
| antimicrobial peptide biosynthetic process | GO:0002777 | 2 | 0.017 | |
| mesoderm development | GO:0007498 | 100 | 0.017 | |
| tricuspid valve development | GO:0003175 | 3 | 0.017 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.017 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.017 | |
| regulation of bmp signaling pathway | GO:0030510 | 60 | 0.017 | |
| antimicrobial peptide production | GO:0002775 | 2 | 0.017 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.017 | |
| rac protein signal transduction | GO:0016601 | 13 | 0.017 | |
| notch signaling pathway | GO:0007219 | 71 | 0.017 | |
| regulation of carbohydrate metabolic process | GO:0006109 | 75 | 0.017 | |
| regulation of skeletal muscle fiber differentiation | GO:1902809 | 3 | 0.017 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.017 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.017 | |
| microtubule based process | GO:0007017 | 236 | 0.017 | |
| leukocyte homeostasis | GO:0001776 | 79 | 0.017 | |
| bundle of his development | GO:0003166 | 4 | 0.017 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.017 | |
| response to inorganic substance | GO:0010035 | 96 | 0.017 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.017 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.017 | |
| gene silencing | GO:0016458 | 38 | 0.017 | |
| skeletal system development | GO:0001501 | 356 | 0.016 | |
| protein homooligomerization | GO:0051260 | 43 | 0.016 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.016 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.016 | |
| rhombomere morphogenesis | GO:0021593 | 2 | 0.016 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.016 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.016 | |
| regulation of cell motility | GO:2000145 | 236 | 0.016 | |
| sulfur compound metabolic process | GO:0006790 | 100 | 0.016 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.016 | |
| olfactory bulb development | GO:0021772 | 30 | 0.016 | |
| positive regulation of mesoderm development | GO:2000382 | 2 | 0.016 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 65 | 0.016 | |
| stem cell maintenance | GO:0019827 | 130 | 0.016 | |
| regulation of rho gtpase activity | GO:0032319 | 58 | 0.016 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.016 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.016 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.016 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.016 | |
| negative regulation of kinase activity | GO:0033673 | 81 | 0.016 | |
| response to starvation | GO:0042594 | 65 | 0.016 | |
| dna recombination | GO:0006310 | 92 | 0.016 | |
| negative regulation of cardiac chamber morphogenesis | GO:1901220 | 2 | 0.016 | |
| stem cell development | GO:0048864 | 219 | 0.016 | |
| positive regulation of mesenchymal cell proliferation involved in ureter development | GO:2000729 | 3 | 0.016 | |
| fertilization | GO:0009566 | 127 | 0.016 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.016 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.016 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.016 | |
| motor neuron axon guidance | GO:0008045 | 26 | 0.016 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.016 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.015 | |
| regulation of synapse structural plasticity | GO:0051823 | 4 | 0.015 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.015 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.015 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.015 | |
| limbic system development | GO:0021761 | 72 | 0.015 | |
| negative regulation of bmp signaling pathway | GO:0030514 | 35 | 0.015 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.015 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.015 | |
| protein localization to membrane | GO:0072657 | 108 | 0.015 | |
| interleukin 8 secretion | GO:0072606 | 3 | 0.015 | |
| mesodermal to mesenchymal transition involved in gastrulation | GO:0060809 | 1 | 0.015 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.015 | |
| epithelial tube formation | GO:0072175 | 130 | 0.015 | |
| regulation of protein transport | GO:0051223 | 163 | 0.015 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.015 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.015 | |
| regulation of cell growth | GO:0001558 | 91 | 0.015 | |
| cranial nerve morphogenesis | GO:0021602 | 26 | 0.015 | |
| signal transduction in absence of ligand | GO:0038034 | 55 | 0.015 | |
| somatic diversification of immune receptors via germline recombination within a single locus | GO:0002562 | 51 | 0.015 | |
| mesenchymal cell development | GO:0014031 | 93 | 0.015 | |
| somite development | GO:0061053 | 81 | 0.015 | |
| tongue muscle cell differentiation | GO:0035981 | 2 | 0.015 | |
| appendage development | GO:0048736 | 166 | 0.015 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.015 | |
| mesoderm formation | GO:0001707 | 62 | 0.015 | |
| regulation of heart growth | GO:0060420 | 31 | 0.015 | |
| regulation of production of molecular mediator of immune response | GO:0002700 | 65 | 0.015 | |
| parasympathetic nervous system development | GO:0048486 | 19 | 0.015 | |
| regulation of cellular carbohydrate metabolic process | GO:0010675 | 75 | 0.015 | |
| blastocyst formation | GO:0001825 | 33 | 0.015 | |
| development of primary female sexual characteristics | GO:0046545 | 73 | 0.015 | |
| aminoglycan metabolic process | GO:0006022 | 34 | 0.015 | |
| regulation of adaptive immune response | GO:0002819 | 90 | 0.015 | |
| positive regulation of transcription from rna polymerase ii promoter involved in heart development | GO:1901228 | 4 | 0.015 | |
| posttranscriptional gene silencing | GO:0016441 | 10 | 0.015 | |
| nephron epithelium morphogenesis | GO:0072088 | 68 | 0.015 | |
| regulation of cardiac chamber formation | GO:1901210 | 1 | 0.014 | |
| cardiac ventricle morphogenesis | GO:0003208 | 50 | 0.014 | |
| ectoderm formation | GO:0001705 | 3 | 0.014 | |
| growth involved in heart morphogenesis | GO:0003241 | 4 | 0.014 | |
| preganglionic parasympathetic nervous system development | GO:0021783 | 17 | 0.014 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.014 | |
| postganglionic parasympathetic nervous system development | GO:0021784 | 2 | 0.014 | |
| mammary gland epithelium development | GO:0061180 | 65 | 0.014 | |
| glucose homeostasis | GO:0042593 | 128 | 0.014 | |
| mammary placode formation | GO:0060596 | 4 | 0.014 | |
| negative regulation of leukocyte differentiation | GO:1902106 | 51 | 0.014 | |
| triglyceride biosynthetic process | GO:0019432 | 17 | 0.014 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.014 | |
| t cell differentiation | GO:0030217 | 174 | 0.014 | |
| response to oxygen levels | GO:0070482 | 62 | 0.014 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.014 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.014 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.014 | |
| planar cell polarity pathway involved in heart morphogenesis | GO:0061346 | 3 | 0.014 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.014 | |
| protein processing | GO:0016485 | 163 | 0.014 | |
| negative regulation of calcium ion dependent exocytosis | GO:0045955 | 3 | 0.014 | |
| regulation of cardiac muscle tissue growth | GO:0055021 | 26 | 0.014 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.014 | |
| intrinsic apoptotic signaling pathway in response to dna damage | GO:0008630 | 57 | 0.014 | |
| ear development | GO:0043583 | 200 | 0.014 | |
| cell differentiation involved in kidney development | GO:0061005 | 33 | 0.014 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.014 | |
| brain segmentation | GO:0035284 | 3 | 0.014 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.014 | |
| kidney epithelium development | GO:0072073 | 121 | 0.014 | |
| formation of organ boundary | GO:0010160 | 1 | 0.014 | |
| cellular response to insulin stimulus | GO:0032869 | 78 | 0.014 | |
| positive regulation of binding | GO:0051099 | 49 | 0.014 | |
| female sex determination | GO:0030237 | 1 | 0.014 | |
| b cell mediated immunity | GO:0019724 | 71 | 0.014 | |
| regulation of organ growth | GO:0046620 | 61 | 0.014 | |
| neuroblast fate determination | GO:0007400 | 1 | 0.013 | |
| anion transport | GO:0006820 | 177 | 0.013 | |
| recognition of apoptotic cell | GO:0043654 | 3 | 0.013 | |
| sinoatrial node cell development | GO:0060931 | 3 | 0.013 | |
| ventral spinal cord development | GO:0021517 | 48 | 0.013 | |
| tissue migration | GO:0090130 | 68 | 0.013 | |
| polysaccharide metabolic process | GO:0005976 | 39 | 0.013 | |
| carboxylic acid biosynthetic process | GO:0046394 | 86 | 0.013 | |
| interleukin 8 production | GO:0032637 | 4 | 0.013 | |
| glycosaminoglycan metabolic process | GO:0030203 | 34 | 0.013 | |
| mitral valve development | GO:0003174 | 4 | 0.013 | |
| aminoglycan biosynthetic process | GO:0006023 | 15 | 0.013 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.013 | |
| smad protein complex assembly | GO:0007183 | 1 | 0.013 | |
| mesenchymal cell differentiation | GO:0048762 | 107 | 0.013 | |
| regulation of actin filament bundle assembly | GO:0032231 | 18 | 0.013 | |
| spermatid development | GO:0007286 | 108 | 0.013 | |
| gluconeogenesis | GO:0006094 | 39 | 0.013 | |
| secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development | GO:0060528 | 4 | 0.013 | |
| morphogenesis of a polarized epithelium | GO:0001738 | 37 | 0.013 | |
| male gonad development | GO:0008584 | 88 | 0.013 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.013 | |
| positive regulation of organ growth | GO:0046622 | 29 | 0.013 | |
| single organism nuclear import | GO:1902593 | 95 | 0.013 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.013 | |
| negative regulation of canonical wnt signaling pathway involved in neural plate anterior posterior pattern formation | GO:0060829 | 1 | 0.013 | |
| maintenance of location | GO:0051235 | 89 | 0.013 | |
| cardiac muscle cell myoblast differentiation | GO:0060379 | 8 | 0.013 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.013 | |
| regulation of peptidyl tyrosine phosphorylation | GO:0050730 | 93 | 0.013 | |
| dendritic spine development | GO:0060996 | 30 | 0.013 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.013 | |
| epidermis development | GO:0008544 | 187 | 0.013 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.013 | |
| response to amino acid | GO:0043200 | 37 | 0.013 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.013 | |
| pulmonary valve formation | GO:0003193 | 1 | 0.013 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.013 | |
| inner ear morphogenesis | GO:0042472 | 101 | 0.013 | |
| leukocyte migration | GO:0050900 | 124 | 0.013 | |
| cardiac cell fate determination | GO:0060913 | 2 | 0.013 | |
| compartment pattern specification | GO:0007386 | 4 | 0.012 | |
| negative regulation of cell projection organization | GO:0031345 | 56 | 0.012 | |
| regulation of circadian rhythm | GO:0042752 | 58 | 0.012 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.012 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.012 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.012 | |
| ossification | GO:0001503 | 216 | 0.012 | |
| hexose biosynthetic process | GO:0019319 | 39 | 0.012 | |
| wnt signaling pathway involved in forebrain neuroblast division | GO:0021874 | 2 | 0.012 | |
| hippocampus development | GO:0021766 | 52 | 0.012 | |
| protein import | GO:0017038 | 101 | 0.012 | |
| somatic diversification of immune receptors | GO:0002200 | 53 | 0.012 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.012 | |
| developmental cell growth | GO:0048588 | 84 | 0.012 | |
| positive regulation of muscle cell differentiation | GO:0051149 | 39 | 0.012 | |
| positive regulation of skeletal muscle fiber differentiation | GO:1902811 | 2 | 0.012 | |
| positive regulation of interleukin 8 production | GO:0032757 | 2 | 0.012 | |
| sensory perception | GO:0007600 | 245 | 0.012 | |
| regulation of jnk cascade | GO:0046328 | 62 | 0.012 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.012 | |
| chondroitin sulfate proteoglycan biosynthetic process | GO:0050650 | 8 | 0.012 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.012 | |
| mesonephros development | GO:0001823 | 97 | 0.012 | |
| inflammatory response | GO:0006954 | 244 | 0.012 | |
| immunoglobulin production involved in immunoglobulin mediated immune response | GO:0002381 | 43 | 0.012 | |
